 |
Articles|
|
 Scientists conclude trial of new wrinkle treatmentPlastic Surgery Overseas site contains latest news about Plastic Surgery Abroad, Cosmetic Surgery Abroad, Aesthetic Plastic Surgery, Affordable Cosmetic Surgery Abroad, Cheap Cosmetic Surgery Abroad. Man of science at biomedical firm Gel-Del Technologies have completed trials of a new designed to improve the visual aspect of furrow. CosmetaLife is an injectable dermal filler that could provide a more effective alternative to existing therapies. The merchandise produced good results than Restylane - the first dermal filler to marketplace over 12 years ago - for the first three calendar month after treatment, and was as effective at 12 calendar month after treatment. Dr David maestro, founder and president of Gel-Del Technologies, commented: "It is exciting to see the first human use of this engineering over the past 19 calendar month. "Based on the consequence of our 12-month clinical study, CosmetaLife provides a good early public presentation than hyaluronic acid merchandise, and a lasting effect expected to persist longer due to an actual dermal rectification." Dr maestro concluded that the company are "pleased" with the clinical trials and "eager" to gain blessing for the filler. More Plastic Surgery Overseas News |